Form D · Biotechnology
AILERON THERAPEUTICS INC
Waltham, MA · CIK 0001420565
Offering snapshot reported Nov 16, 2023 · SEC filing
- Reported sold
- $18.3M Offering amount: $18.3M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2023 | Initial | $18,254,247 | No comparison | 15 | SEC filing |
| Jan 6, 2017 | Initial | $30,112,894 | No comparison | 11 | SEC filing |
| Oct 29, 2014 | Initial | $19,799,999 | No comparison | 13 | SEC filing |
| Nov 19, 2013 | Initial | $15,000,003 | No comparison | 11 | SEC filing |
| Jun 12, 2009 | Initial | $28,105,002 | No comparison | 8 | SEC filing |
| Dec 3, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $753K
- Finders' fees
- $0
- Form D file number
- 021-497394
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Clear Street LLC | 288933 | |
| Arcadia Securities, LLC | 44656 |
Source: Form D, filed Nov 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Manuel Aivado | Executive |
| Manuel Alves Aivado, M.D., Ph.D. | Director, Executive |
| Reinhard J. Ambros | Director |
| Michael Diem | Director |
| Susan L. Drexler | Executive |
| William Fairey | Director |
| Brian M. Gallagher, Jr. | Director |
| Seth L. Harrison | Director |
| Scott Kapnick | Director |
| John H. Mc Arthur | Director |
| Campbell Murray | Director |
| Alan Musso | Director |
| Enrico Petrillo | Director |
| Armen Shanafelt | Director |
| Nolan Sigal, M.D., Ph.D. | Director |
| Josef H. Von Rickenbach | Director |
| Caleb Winder | Director |
| Brian Windsor, Ph.D. | Executive |
| Joseph A. Yanchik Iii | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
738 Main Street Unit 398
Waltham, MA, 02451
Waltham, MA, 02451